A recent study demonstrated that a monoclonal antibody, LTBP-49247, which binds selectively to TGF-β1 in latent complex with LTBPs, reduces renal fibrosis in Col4a3-null mouse model of Alport syndrome and the rat adenine model of kidney disease 136. The gene discussed is COL4A3; the disease is Alport syndrome.